Efficacy and tolerability of the antispasmodic, pridinol, in patients with muscle-pain – results of primepain, a retrospective analysis of open-label real-world data provided by the German pain E-registry

References

• GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1211–1259.
   PubMed Web of Science ®Google Scholar
• Hoy D, Bain C, Williams G, et al. A systematic review of the global prevalence of low back pain. Arthritis Rheum. 2012;64(6):2028–2037.
   PubMed Web of Science ®Google Scholar
• von der Lippe E, Krause L, Porst M, et al. Prävalenz von rücken- und nackenschmerzen in deutschland. Ergebnisse der Krankheitslast-Studie BURDEN 2020. J Health Monit. 2021;6(S3):2–14.
   Google Scholar
• O’Sullivan P. Diagnosis and classification of chronic low back pain disorders: maladaptive movement and motor control impairments as underlying mechanism. Man Ther. 2005;10(4):242–255.
   PubMed Web of Science ®Google Scholar
• Deyo RA, Weinstein JN. Low back pain. N Engl J Med. 2001;344(5):363–370.
   PubMed Web of Science ®Google Scholar
• O’Sullivan P. It’s time for change with the management of non-specific chronic low back pain. Br J Sports Med. 2012;46(4):224–227.
   PubMed Web of Science ®Google Scholar
• National Institute of Health. Low Back Pain Fact Sheet. 2019; [cited 2020 Feb 21]. Available from: https://www.ninds.nih.gov/disorders/patient-caregiver-education/fact-sheets/low-back-pain-fact-sheet.
   Google Scholar
• O’Sullivan PB, Caneiro JP, O’Sullivan K, et al. Back to basics: 10 facts every person should know about back pain. Br J Sports Med. 2020;54(12):698–699.
   PubMed Web of Science ®Google Scholar
• Di Iorio D, Henley E, Doughty A. A survey of primary care physician practice patterns and adherence to acute low back problem guidelines. Arch Fam Med. 2000;9(10):1015–1021.
   PubMedGoogle Scholar
• Chou R, Qaseem A, Snow V, et al. Clinical efficacy assessment subcommittee of the American College of Physicians; American College of Physicians; American Pain Society Low Back Pain Guidelines Panel. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med. 2007;147(7):478–491.
   PubMed Web of Science ®Google Scholar
• Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftli-chen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Nicht-spezifischer Kreuzschmerz – Langfassung, 2. Auflage. Version 1. 2017; [cited 2002 Feb 21]. Available from: https://www.leitlinien.de/themen/kreuzschmerz/2-auflage.
   Google Scholar
• Schers H, Braspenning J, Drijver R, et al. Low back pain in general practice: reported management and reasons for not adhering to the guidelines in The Netherlands. Br J Gen Pract. 2000;50(457):640–644.
   PubMed Web of Science ®Google Scholar
• Oliveira CB, Maher CG, Pinto RZ, et al. Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overview. Eur Spine J. 2018;27(11):2791–2803.
   PubMed Web of Science ®Google Scholar
• Ivanova JI, Birnbaum HG, Schiller M, et al. Real-world practice patterns, health-care utilization, and costs in patients with low back pain: the long road to guideline-concordant care. Spine J. 2011;11(7):622–632.
   PubMed Web of Science ®Google Scholar
• Bishop PB, Wing PC. Knowledge transfer in family physicians managing patients with acute low back pain: a prospective randomized control trial. Spine J. 2006;6(3):282–288.
   PubMedGoogle Scholar
• Piccoliori G, Engl A, Gatterer D, et al. Management of low back pain in general practice – is it of acceptable quality: an observational study among 25 general practices in South Tyrol (Italy). BMC Fam Pract. 2013;14:148.
   PubMed Web of Science ®Google Scholar
• Williams CM, Maher CG, Hancock MJ, et al. Low back pain and best practice care: a survey of general practice physicians. Arch Intern Med. 2010;170(3):271–277.
   PubMedGoogle Scholar
• Di Gangi S, Pichierri G, Zechmann S, et al. Prescribing patterns of pain medications in unspecific low back pain in primary care: a retrospective analysis. J Clin Med. 2021;10(7):1366.
   PubMedGoogle Scholar
• Back-Report Switzerland. 2020. Rheumaliga Schweiz Juli 2020; [cited 2022 Feb 21]. Available from: https://www.rheumaliga.ch/assets/doc/CH_Dokumente/blog/2020/rueckenreport-2020/Rueckenreport-2020.pdf.
   Google Scholar
• [cited 2022 Feb 21]. Available from: https://www.bfarm.de/SharedDocs/Downloads/DE/Arzneimittel/Pharmakovigilanz/PSUSAS/s-z/tizanidin_beschluss_cmdh.pdf?__blob=publicationFile&v=2.
   Google Scholar
• [cited 2022 Feb 21]. Available from: https://www.ema.europa.eu/en/documents/press-release/european-medicines-agency-recommends-restricting-use-tolperisone-medicines_en.pdf.
   Google Scholar
• [cited 2022 Feb 21]. Available from: https://www.ema.europa.eu/en/documents/press-release/recommendation-suspend-tetrazepam-containing-medicines-endorsed-cmdh_en.pdf.
   Google Scholar
• [cited 2022 Feb 21]. Available from: https://www.ema.europa.eu/en/documents/referral/prac-recommends-marketing-authorisation-painkiller-flupirtine-be-withdrawn_en.pdf.
   Google Scholar
• Pridinol. Myopridin® 3 mg tablets (Strathmann) summary of product characteristics, last updated Aug 2019.
   Google Scholar
• Pridinol – central and peripheral muscle spasms, lumbalgia, torticollis and general muscle pain. Article in German; [cited 2022 Feb 21]. Available from: https://www.kbv.de/media/sp/WirkstoffAktuell_4-21_Pridinol.pdf.
   Google Scholar
• GKV-Arzneimittelindex im Wissenschaftlichen Institut der AOK (WIdO): Deutsches Institut für Medizinische Dokumentation und Information (DIMDI) (Hrsg.): Anatomisch-therapeutisch-chemische Klassifikation mit Tagesdosen. Amtliche Fassung des ATC-Index mit DDD-Angaben für Deutschland im Jahre 2021. Berlin: DIMDI, 2021.
   Google Scholar
• Forth W, Henschler D, Rummel W, et al. [Allgemeine und spezielle pharmakologie und toxikologie], 6th edition. Mannheim, Leipzig, Wien, Zurich: BI‐Wissenschaftsverlag; 1992.
   Google Scholar
• Stock B, Spiteller G. Metabolism of antiparkinson drugs. An example of competitive hydroxylation. Arzneimittelforschung. 1979;29(4):610–615.
   PubMedGoogle Scholar
• Richter M, Donath F, Wedemeyer RS, et al. Pharmacokinetics of oral pridinol: results of a randomized, crossover bioequivalence trial in healthy subjects. Int J Clin Pharmacol Ther. 2021;59(6):471–477.
   PubMedGoogle Scholar
• Deutsche Schmerzgesellschaft. Deutscher Schmerzfragebogen [German pain questionnaire]; [cited 2022 Feb 21]. Available from: http://www.dgss.org/deutscher-schmerzfragebogen. (German).
   Google Scholar
• Deutsche Schmerzgesellschaft. Handbuch zum Deutschen Schmerzfragebogen [Manual for the German pain questionnaire]; [cited 2022 Feb 21]. Available from: http://www.dgss.org/fileadmin/pdf/12_DSF_Manual_2012.2.pdf. (German).
   Google Scholar
• Kassenärztliche Bundesvereinigung. Qualitätssicherungsvereinbarung zur schmerztherapeutischen Versorgung chronisch schmerzkranker Patienten gem. § 135 Abs. 2 SGB V. (Qualitätssicherungsvereinbarung Schmerztherapie); [cited 2022 Feb 21]. Available from: https://www.kbv.de/media/sp/Schmerztherapie.pdf. (German).
   Google Scholar
• Tait RC, Chibnall JT, Krause S. The pain disability index: psychometric properties. Pain. 1990;40(2):171–182.
   PubMed Web of Science ®Google Scholar
• Basler HD. Marburger fragebogen zum habituellen Wohlbefinden – Untersuchung an patienten mit chonischem schmerz [the marburg questionnaire on habitual health findings – a study on patients with chronic pain]. Schmerz. 1999;13(6):385–391. German.
   PubMed Web of Science ®Google Scholar
• Überall MA. DGS-PraxisRegister schmerz. Von der pflicht zur kür – standardisierte dokumentation in der schmerzmedizin. Schmerzmed. 2016;32(4):36–56.
   Google Scholar
• Morris SB, DeShon RP. Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs. Psychol Methods. 2002;7(1):105–125.
   PubMed Web of Science ®Google Scholar
• Morris SB. Estimating effect sizes from pretest-posttest-control group designs. Organizational Res Meth. 2008;11(2):364–386.
   Web of Science ®Google Scholar
• Lanas A, Garcia-Tell G, Armada B, et al. Prescription patterns and appropriateness of NSAID therapy according to gastrointestinal risk and cardiovascular history in patients with diagnoses of osteoarthritis. BMC Med. 2011;9:38.
   PubMed Web of Science ®Google Scholar
• Ramos H, Moreno L, Pérez-Tur J, et al. CRIDECO anticholinergic load scale: an updated anticholinergic burden scale. Comparison with the ACB scale in Spanish individuals with subjective memory complaints. J Pers Med. 2022;12(2):207.
   PubMedGoogle Scholar
• Beyeler J. Zur therapie des paravertebralen hartspanns mit lyseen. Orthopädische Praxis. 1975;(XI):796.
   Google Scholar